Atlas Trials

Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma

Clinical trial NCT04649476 · COMPLETED

Trial details

NCT number
NCT04649476
Sponsor
Hospital of Stomatology, Wuhan University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Oral Squamous Cell Carcinoma
Start date
2021-03-22
Primary completion
2022-08-10
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.